Free Press. Used - Good. Good condition. Good dust jacket. 2nd edition. A copy that has been read but remains intact. May contain markings such as bookplates, stamps, limited notes and highlighting, or a few light stains. Bundled media such as CDs, DVDs, floppy disks or access codes may not be included. Free Press ISBN 0684827379 9780684827377 [US]

Free Press. Used - Good. Former library book; may include library markings. Used book that is in clean, average condition without any missing pages. Free Press ISBN 0684827379 9780684827377 [US]

Very Good. small rip on dust cover ISBN 0684827379 9780684827377 [US]

Free Press, Date: 1996-05-01. hardcover. New. 6x1x9. 1996. Free Press ISBN 0684827379 9780684827377 [US]

New York: The Free Press, Date: 1996. Second Edition First Printing . Hard Back. Near Fine/Very Good. 6" x 9 1/2. 534 Pages Indexed. Owner's name on front endpaper. No other marks or stamps. Flawless interior.An excellent reference on mental and emotional disorders, interventions and therapies, medications and their biochemical effects, effects over the full course of the therapy, drug names and classifications, diagnosis and case study examples, drug histories, side effects, and special considerations. The last 25 years have witnessed an explosion of knowledge about the influence of brain biochemistry on mood and behaviour and about pharmacological approaches to treating mental and emotional disorders. A substantial portion of patients seen in clinical practice are taking some medication or might usefully be advised to do so. But many clinical psychologists, social workers, and counselors need additonal information in order to better treat patients already on medication, know when and to whom to refer new patients for psychiatric consultation, and work collaboratively with psychiatrists when appropriate. This new second edition reflects major changes that influenced the clinical arena in the last five years such as the recent release of DSM-IV and the domination of psychopharmacological field by the selective serotonin reuptake inhibitors, such as Prozac. Now includes coverage of attention deficit/hyperactivity disorder and contains updated sections on the ...